Post-remission therapy with allogeneic stem cell transplantation from an HILA-matched family donor in younger patients with acute myeloid leukaemia exhibiting a normal karyotype:: differential effects of molecular markers

被引：0
|
作者：
Schlenk, RF
Corbacioglu, A
Krauter, J
Fröhling, S
Bunjes, D
Späth, D
Schäfer, I
Döhner, H
Ganser, A
Döhner, K
机构：
[1] Univ Ulm, Ulm, Germany
[2] Hannover Med Sch, D-3000 Hannover, Germany
[3] Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
BONE MARROW TRANSPLANTATION | 2006年 / 37卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S2 / S2
页数：1
相关论文
共 50 条
  • [1] Myeloablative therapy and autologous or allogeneic marrow and stem cell transplantation are equivalent post-remission therapies in acute myeloid leukaemia.
    Novitzky, N
    Thomas, V
    BLOOD, 1996, 88 (10) : 3834 - 3834
  • [2] Allogeneic stem cell transplantation in acute myeloid leukaemia with normal karyotype: a risk factor analysis in 247 patients, based on molecular markers and stage at transplantation
    Pfeiffer, T.
    Schleuning, M.
    Eder, M.
    Tischer, J.
    Braess, J.
    Spiekermann, K.
    Bunjes, D.
    Greinix, H.
    Bug, G.
    Holler, E.
    Oruzio, D.
    Krejci, M.
    Scheid, C.
    Gerbitz, A.
    Kolbe, K.
    Meyer, R. G.
    Arnold, R.
    Christopeit, M.
    Baurmann, H.
    v. Harsdorf, S.
    Bethge, W. A.
    Dammann, E.
    Rothmayer, M.
    Franke, A.
    Schnittger, S.
    Mayer, J.
    Schlimok, G.
    Schwerdtfeger, R.
    Ganser, A.
    Kolb, H. -J.
    Schmid, C.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S10 - S11
  • [3] Allogeneic stem cell transplantation is the optimal post-remission therapy in minimal residual disease positive patients with acute myeloid leukemia
    Gianni, L.
    Buccisano, F.
    Maurillo, L.
    Del Poeta, G.
    Del Principe, I
    Ottaviani, I
    Sarlo, C.
    Ammatuna, E.
    Campagna, S.
    Imo Consalvo, M.
    Amadori, A.
    Venditti, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 69 - 69
  • [4] Postremission therapy with an allogeneic transplantation from an HLA-matched family donor seems to overcome the negative prognostic impact of FLT3-ITD in younger patients with acute myeloid leukemia exhibiting a normal karyotype.
    Schlenk, RF
    Krauter, J
    Fröhling, S
    Späth, D
    Schäfer, I
    Hein, S
    Döhner, H
    Ganser, A
    Döhner, K
    BLOOD, 2005, 106 (11) : 662A - 662A
  • [5] Post-remission treatment with allogeneic stem cell transplantation in patients aged 60 years and older with acute myeloid leukaemia: a time-dependent analysis
    Versluis, Jurjen
    Hazenberg, Carin L. E.
    Passweg, Jakob R.
    van Putten, Wim L. J.
    Maertens, Johan
    Biemond, Bart J.
    Theobald, Matthias
    Graux, Carlos
    Kuball, Jurgen
    Schouten, Harry C.
    Pabst, Thomas
    Lowenberg, Bob
    Ossenkoppele, Gert
    Vellenga, Edo
    Cornelissen, Jan J.
    LANCET HAEMATOLOGY, 2015, 2 (10): : E427 - E436
  • [6] Autologous or allogeneic stem cell transplantation as post-remission therapy in refractory or relapsed acute myeloid leukemia after highly intensive chemotherapy
    Thomas, X
    Le, QH
    De Botton, S
    Raffoux, E
    Chelghoum, Y
    Pautas, C
    Dreyfus, F
    Dhedin, N
    Vekhoff, A
    Troncy, J
    Pigneux, A
    De Revel, T
    Reman, O
    Travade, P
    Thiebaut, A
    Guerci, A
    Elhamri, M
    Fenaux, P
    Dombret, H
    Michallet, M
    LEUKEMIA & LYMPHOMA, 2005, 46 (07) : 1007 - 1016
  • [7] Comparison of the impact of two post-remission therapy regimens on cardiac events in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation
    Jin Hayakawa
    Hideki Nakasone
    Daisuke Minakata
    Shin-ichiro Fujiwara
    Ayumi Gomyo
    Yu Akahoshi
    Yusuke Komiya
    Naonori Harada
    Tomotaka Ugai
    Kazuaki Kameda
    Hidenori Wada
    Yuko Ishihara
    Koji Kawamura
    Kana Sakamoto
    Miki Sato
    Kiriko Terasako-Saito
    Misato Kikuchi
    Shun-ichi Kimura
    Junya Kanda
    Shinichi Kako
    Yoshinobu Kanda
    International Journal of Hematology, 2022, 116 : 239 - 247
  • [8] Comparison of the impact of two post-remission therapy regimens on cardiac events in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation
    Hayakawa, Jin
    Nakasone, Hideki
    Minakata, Daisuke
    Fujiwara, Shin-ichiro
    Gomyo, Ayumi
    Akahoshi, Yu
    Komiya, Yusuke
    Harada, Naonori
    Ugai, Tomotaka
    Kameda, Kazuaki
    Wada, Hidenori
    Ishihara, Yuko
    Kawamura, Koji
    Sakamoto, Kana
    Sato, Miki
    Terasako-Saito, Kiriko
    Kikuchi, Misato
    Kimura, Shun-ichi
    Kanda, Junya
    Kako, Shinichi
    Kanda, Yoshinobu
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 116 (02) : 239 - 247
  • [9] The effect of allogeneic stem cell transplantation on outcome in younger acute myeloid leukemia patients with minimal residual disease detected by flow cytometry at the end of post-remission chemotherapy
    Laane, Edward
    Derolf, Asa Rangert
    Bjorklund, Elisabet
    Mazur, Joanna
    Everaus, Hele
    Soderhall, Stefan
    Bjorkholm, Magnus
    Porwit-MacDonald, Anna
    HAEMATOLOGICA, 2006, 91 (06) : 833 - 836
  • [10] Allogeneic stem cell transplantation in younger patients with acute myeloid leukemia in first complete remission: application of sibling and matched unrelated donors
    Cornelissen, Jan J.
    ANNALS OF HEMATOLOGY, 2008, 87 : S44 - S47
12345